Baxter’s Renal Care Unit spinoff Vantive is launched

Vantive Korea launched independently with its global entity, seeks to expand business

Building on 70 years of kidney care leadership and innovation, the company plans to continue providing treatment options

Will focus on expanding the potential to extend patient lives in more than 100 countries

With the acquisition process complete for Baxter's Renal Care business, it has newly launched as Vantive, a new company specializing in kidney and life-sustaining organ therapies.

 

The spin-off follows the acquisition of Baxter's Kidney Care business by funds managed by global investment firm The Carlyle Group.

 

As an independent company, Vantive will focus on raising the standard of kidney and vital organ care to help patients around the world live richer, longer lives.

 

Its strategy for advancing life-sustaining organ care will empower patients and healthcare providers to take more control of their care by helping to break down barriers to starting and maintaining treatment.

 

In particular, Vantive will build on its 70-year legacy of innovation in kidney care to fulfill its mission of “Extending Lives, Expanding Possibilities.” “For patients starting dialysis and for caregivers struggling to save lives in the intensive care unit, it's critical to provide the right treatment at the right time,” said Chris Toth, CEO of Vantive.

 

”Our core focus is to support patients and caregivers in these moments by providing better choices, greater autonomy, and greater possibilities.

 

“Vantive is ushering in a new era of innovation in life-sustaining long-term care, and we look forward to working with our 23,000 employees around the world to make a difference for millions of patients and families.” Vantive provides innovative products, digitally enhanced solutions and advanced services to support dialysis at home and in the hospital, and treatment options to support kidney and vital organ function in critically ill patients.

 

Patients in more than 100 countries around the world use Vantiv's solutions and services more than one million times every day, representing an opportunity to deliver more than one million improved treatment experiences every day.

 

Through innovative integrated devices, Vantive also aims to help healthcare providers deliver care more efficiently and patients receive treatment while maintaining their daily routines.

 

“The launch of Vantive marks a significant milestone in the continued evolution of kidney care and life-sustaining organ support,” said Kieran Gallahue, Chairman of the Board of Directors at Vantive.

 

”Vantive is focused on providing better connectivity, visibility, and insight throughout the patient's care journey.

 

Robert Schmidt, Global Co-Head of Carlyle Healthcare, added, “We are excited to partner with Vantive to expand its global impact and realize sustainable growth.

 

In this new journey, we look forward to actively supporting Vantive's ongoing innovation to improve patient access to care, quality and outcomes, and clinician efficiency.